Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2011
01/06/2011US20110002855 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues
01/06/2011US20110002027 Electrochromic material and electrochromic device including the same
01/06/2011US20110001129 Substituted bipyridyl compound and organic electroluminescent device
01/06/2011CA2766882A1 Therapeutic compounds and compositions
01/06/2011CA2766873A1 Therapeutic compositions and related methods of use
01/06/2011CA2764185A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
01/05/2011EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands
01/05/2011EP2270004A1 Caspase inhibitors and uses thereof
01/05/2011EP2270001A1 Indolylmaleimide derivatives as PKC inhibitors
01/05/2011EP2270000A1 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
01/05/2011EP2269999A1 Method for preparing crystalline s-omeprazole strontium hydrate
01/05/2011EP2269993A1 2-aminoquinazoline derivative
01/05/2011EP2268633A1 Pyridazinone glucokinase activators
01/05/2011EP2268632A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
01/05/2011EP2268631A1 Aminopiperidinyl derivatives and uses thereof
01/05/2011EP2268630A2 Hexahydrocyclopentylýf¨indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
01/05/2011EP2268628A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
01/05/2011EP2268624A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
01/05/2011EP1881977B1 Histone deacetylase inhibitors
01/05/2011EP1633726B1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
01/05/2011EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain
01/05/2011CN101939313A 3,8-diaminotetrahydroquinoline derivative
01/05/2011CN101939312A Gamma secretase modulators
01/05/2011CN101939311A Heterocyclic compounds with affinity to muscarinic receptors
01/05/2011CN101939302A Mesoionic pesticides
01/05/2011CN101939300A 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid CB1 receptor modulators
01/05/2011CN101939296A Carbazole-containing materials in phosphorescent light emitting diodes
01/05/2011CN101939055A 2-aminoquinolines
01/05/2011CN101939053A Soluble guanylate cyclase activators
01/05/2011CN101935317A Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof
01/05/2011CN101935316A Quinazoline compound and application thereof
01/05/2011CN101935315A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
01/05/2011CN101935303A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
01/05/2011CN101935301A Modulators of ATP-binding cassette transporters
01/05/2011CN101935298A Bipiridine derivative and organic electroluminescence element containing the same
01/05/2011CN101933926A Indolylmaleimde derivatives as PKC inhibitors
01/04/2011US7863454 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
01/04/2011US7863450 e.g. 1-{3-[4-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)phenoxy]propyl}piperidine; histamine H3 receptor antagonist; anxiolytic agent, antidepressant, cognition activator; neurodegenerative diseases, eating disorder, attention deficit disorder, Alzheimer's, Parkinson's diseases, schizophrenia
01/04/2011US7863446 Heterocycles
01/04/2011US7863314 Pyrazole and/or imidazole based compounds; inflammatory diseases and disorders; synthesis
01/04/2011US7863305 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors
01/04/2011US7863293 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count
01/04/2011US7863292 modulators of hypoxia inducible factors and/or endogenous erythropoietin, such as 1-Chloro-4-hydroxy-7-isopropoxy-isoquinoline-3-carboxylic acid (2-hydroxy-1-hydroxymethyl-ethyl)-amide, used for the treatment of anemic disorders, neurological disorders and/or injuries
01/04/2011US7863282 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles
01/04/2011US7863280 poly(ADP-ribose) polymerase (PARP) inhibitors, such as 3-(5-ethyl-2-methyl-6-oxo-1,6-dihydropyridin-3-ylamino)benzonitrile, used for the treatment of ischemia, reperfusion injuries, cardiovascular disorders or myocardium necrosis
01/04/2011US7863266 Therapeutic pyrazoloquinoline urea derivatives
01/04/2011US7863264 Complex of silver and ligand; bactericides, viricides, fungicides
01/04/2011US7863220 Herbicidal pyrimidines
01/04/2011CA2577667C 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie
01/04/2011CA2574926C 1,1,2,2-tetra(hetero)arylethanes or 1,1,2-tri(hetero)aryl-2-heterocyclylethanes as potassium channel inhibitors
01/04/2011CA2555331C Therapeutic agents
01/04/2011CA2521271C Quinoline-2-one-derivatives for the treatment of airways diseases
01/04/2011CA2465207C Pyrazole-amides and -sulfonamides
01/04/2011CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
01/04/2011CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same
01/04/2011CA2458533C Imidazole derivates as anti-inflammatory agents
01/04/2011CA2451241C Unsymmetrical cyclic diamine compound
01/04/2011CA2451238C Cyclic diamine compound with 5 membered ring groups
01/04/2011CA2445251C Crystalline form of omeprazole
01/04/2011CA2421228C Polyarylcarboxamides useful as lipid lowering agents
01/04/2011CA2416274C N-phenyl-2-pyrimidine-amine derivatives
01/04/2011CA2413426C Methods and compositions utilizing quinazolinones
01/04/2011CA2412941C Piperidine compounds for use as ccr-3 inhibitors
01/04/2011CA2375008C Phenoxypropylamine compounds
01/04/2011CA2360451C N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
01/04/2011CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/2010
12/30/2010US20100331549 Novel compounds useful for modulating abnormal cell proliferation
12/30/2010US20100331548 Solid-state form of amg 706 and pharmaceutical compositions thereof
12/30/2010US20100331547 Process for making organic compounds and the organic compounds made therefrom
12/30/2010US20100331509 Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials
12/30/2010US20100331375 Biphenyl compounds useful as muscarinic receptor antagonists
12/30/2010US20100331371 Methyl-benzimidazole derivatives
12/30/2010US20100331369 Therapeutic Agents Useful for Treating Pain
12/30/2010US20100331360 3-substituted sulfonyl piperidine derivative
12/30/2010US20100331351 Methods and compositions for treating bacterial infection
12/30/2010US20100331346 Beta-amino acid derivatives for treatment of diabetes
12/30/2010US20100331342 Immuno Inhibitory Pyrazolone Compounds
12/30/2010US20100331339 (1-azinone)-substituted pyridoindoles
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331326 Inhibitors of CYP 17
12/30/2010US20100331324 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
12/30/2010US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/30/2010US20100331317 Benzodiazepine compound and pharmaceutical composition
12/30/2010US20100331312 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
12/30/2010US20100331307 Therapeutic compounds and compositions
12/30/2010US20100331306 Heterocyclic compounds and their uses
12/30/2010US20100331304 Compounds Which Modulate The CB2 Receptor
12/30/2010US20100331303 Prolyl hydroxylase inhibitors and methods of use
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100331301 Azetidine compound and pharmaceutical use thereof
12/30/2010US20100331298 Carboxamide Compounds and Their Use
12/30/2010US20100331295 Modulators of lxr
12/30/2010US20100331293 Heterocyclic compounds and their uses
12/30/2010US20100330069 Heterocyclic compounds and methods of use
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/30/2010US20100329998 Novel heterocycles
12/29/2010WO2010151791A1 Heterocyclic compounds and their uses
12/29/2010WO2010151740A2 Heterocyclic compounds and their uses
12/29/2010WO2010151737A2 Heterocyclic compounds and their uses
12/29/2010WO2010151735A2 Heterocyclic compounds and their uses